Our faculty's National Health and Medical Research Council (NHMRC) funding success
Our researchers are leading the way in health—with the University of Adelaide receiving a $21.8 million injection in funding for new research.
The funding, from the National Health and Medical Research Council (NHMRC), will support 29 new projects led by University of Adelaide researchers. It will help us to tackle some of the world’s most significant health problems.
The University's Deputy Vice-Chancellor (Research), Professor Julie Owens, says "The latest NHMRC funding will support breakthrough discoveries in women's and children's health, cancer, diabetes, cardiovascular health, infection control, diet and nutrition, oral health, and traumatic brain injury."
Meet our successful researchers:
With a whopping $1,462,925, Professor Sarah Robertson and her team will look into the male partner’s contribution to a woman’s immune system response to the ‘foreign’ foetus, to help promote complication-free pregnancies and the birth of healthy infants.
Professor Marianne Chapman and her team have been awarded $1,233,268 to lay the groundwork for understanding the role of protein in the nutritional support of patients with critical illness, which will help them to later establish the optimum amount and type of protein to improve muscle strength, functional outcomes and survival.
Associate Professor Loc Do and his team aim to use $1,229,852 to examine the effects of socioeconomic circumstances on child oral health conditions, which can be mediated by dietary patterns, use of fluoride and dental service.
Professor Timothy Hughes and his team have a huge $1,162,778 to advance their pioneering concept that some patients can stop their therapy for chronic myeloid leukaemia and not relapse (i.e. treatment free remission).
Professor Ben Mol and his team have a brand new $1,103,273 to better predict and prevent spontaneous preterm birth.
With the help of $998,754 in funding, Professor Wayne Tilley and his team will look for new treatments for breast and prostate cancers that kill more than 6000 Australians each year.
Associate Professor Leonie Heilbronn and her team now have $987,047 to look into intermittent fasting as a nutritional strategy for managing obesity and its effects on metabolic health and weight in people with pre-diabetes.
Professor Stan Gronthos and his team has a handy $850,228 to help investigate the molecular pathways and associated epigenetic changes that skeletal integrity during ageing and bone disease.
Professor Paul Reynolds and his team will use $826,913 to design and test a new treatment for pulmonary vascular disease using cells and cell-derived products as a therapy.
Doctor Tongzhi Wu and his team have been awarded $725,276 to understand how bitter tastes can reduce appetite and slow the emptying of meals from the stomach; how this effects health and type 2 diabetes; and whether this process can be targeted to provide new diabetes treatments.
The only effective treatment for Gastric Adenocarcinoma and Proximal Polyposis of the Stomach (GAPPS) is to surgically remove the stomach—but with the significant post-operative complications this causes, Associate Professor Daniel Worthley and his team will use $724,876 to find new approaches.
Professor Michael Davies and his team have $714,792 to provide urgently needed, robust evidence to guide patient and clinical decisions around infertility treatments where some traditional treatments cause adverse outcomes, including neonatal death and birth defects.
Giving premature babies the omega-3 DHA has been thought to improve their mental development, but Doctor Carmel Collins and their team aim to use $703,371 to find out the important longer-term effects of extra DHA in the first months of life.
Professor Sarah Robertson will also lead a team to develop a therapy to prevent or delay premature births, with the help of $690,821.
Doctor Peter Zalewski and his team have been awarded $685,940 to investigate zinc and ZIP2 in relation to protection against cigarette smoke and cardiovascular disease.
Professor David Findlay and his team have $634,359.30 to develop the research around osteoarthritis.
Doctor Susan Woods and her team will use $593,854 to develop new, complex models of colorectal cancer using genome engineering to test how these changes affect drug therapies—and they’ll develop a better test to detect hidden pre-cancers not currently well detected by population screening.
Professor Andrew Zannettino and his team have been awarded $570,585 to investigate the conditions under which multiple myeloma grows to see if targeted therapies can delay growth.
Clomiphene citrate has been the first line treatment in female infertility internationally since the 1960s, but Professor Michael Davies and his team aim to use $562,194 to show how it’s associated with adverse outcomes so as to inform change.
Professor Stan Gronthos and another of his teams will use $548,854 to develop a treatment to present the premature fusion of cranial sutures in children with Saethre-Chotzen Syndrome.
Professor Raymond Rodgers and his team think they have found a type of damage that effects eggs before ovulation, and they will use $536,978 to try to prove this theory and devise strategies to lower the risk.
Associate Professor Benedetta Sallustio and her team will be working with $327,214 to develop new medications that prevent heart damage during cancer chemotherapy.
Professor Peng Bi and his team will use $300,922 to look into the health care costs of heatwaves versus the benefits of heat health intervention—research that is needed to support evidence-based policies around heat and health.
Professor Jodie Dodd and her team have $287,316 to investigate the effects of dietary and lifestyle interventions among pregnant women who are overweight or obese on longer-term maternal and early childhood outcomes.
Associate Professor Toby Hughes and his team have been awarded $284,652 to examine the changes in oral bacteria over time, and the development and progression of dental decay in Australian children.